GRAIL develops Galleri, a blood test that screens for many types of cancer at once. It last closed at $105.88 on Nov 17, up 0.27% on the day. The average 12-month price target from 9 analysts is $136.44 (+28.9% from the last close), with a high of $180.00 and a low of $100.00. Analyst consensus is Buy, based on the latest ratings from 9 firms (5 buy, 4 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in GRAL, 50% of them bullish and 50% bearish. In the past 30 days there were 1 dark pool print totaling $535K, the largest $535K.
Each firm's latest rating on GRAL in the past 90 days
Average 12-month target
$136.44
▲ 28.9% upside
Based on 9 analysts who set a price target on GRAL in the past 90 days. The average target is $136.44, with a high of $180.00 and a low of $100.00, compared with the last close of $105.88.
Low $100.00Avg $136.44High $180.00
Blue marker: last close $105.88
Highest target$180.00
Average target$136.44
Lowest target$100.00
Latest rating changes
Piper SandlerTarget raised
Nov 10Hold$54 → $130
RBC CapitalTarget raised
Nov 5Hold$84 → $100
Morgan StanleyMaintained
Oct 13Hold$120
TD CowenMaintained
Oct 13Buy$180
UBSTarget raised
Oct 2Buy$105 → $175
Date
Firm
Action
Rating
Price target
Nov 10
Piper Sandler
Target raised
Hold
$54 → $130
Nov 5
RBC Capital
Target raised
Hold
$84 → $100
Oct 13
Morgan Stanley
Maintained
Hold
$120
Oct 13
TD Cowen
Maintained
Buy
$180
Oct 2
UBS
Target raised
Buy
$105 → $175
Loading…
Technical Analysis
GRAL · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, nearing oversold
The stock is 24% below its 20 day and 16% below its 50 day average. It is 25% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 38), near oversold. The nearest support is the Pivot at $105.29, and the nearest resistance the Pivot R1 at $111.01.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 10.6%/day
Key levels
$166.4852 week high+57.2%
$144.18Swing high (Oct 14)+36.2%
$131.3820 day average+24.1%
$122.4750 day average+15.7%
$111.01Pivot R1+4.8%
$105.88Last close
$105.29Pivot−0.6%
$100.16Pivot S1−5.4%
$97.60100 day average−7.8%
$79.30200 day average−25.1%
$76.60Swing low (Aug 31)−27.7%
$41.5052 week low−60.8%
Indicators
RSI (14)
37.86
Weak, oversold below 30
Neutral
MACD
-4.02
Below its signal line
Bearish
Stochastic
5.2
Near the bottom of its range
Oversold
ADX (14)
27.7
Trending down
Williams %R
-89.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-154.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−24.1%
Change over 10 sessions
Bearish
ATR (14)
$11.25
Typical daily range, 10.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityNormal, 17.4%/day
Key levels
$166.4852 week high+57.2%
$144.18Swing high (Oct 14)+36.2%
$131.3820 day average+24.1%
$122.4750 day average+15.7%
$111.01Pivot R1+4.8%
$105.88Last close
$105.29Pivot−0.6%
$100.16Pivot S1−5.4%
$97.60100 day average−7.8%
$79.30200 day average−25.1%
$76.60Swing low (Aug 31)−27.7%
$41.5052 week low−60.8%
Indicators
RSI (14)
53.36
Middle of its range
Neutral
MACD
14.67
Above its signal line
Bullish
Stochastic
48.6
Middle of its range
Neutral
ADX (14)
35.3
Trending up
Williams %R
-60.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
18.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+38.9%
Change over 10 sessions
Bullish
ATR (14)
$18.38
Typical daily range, 17.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for GRAL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GRAL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow is mixed2 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in GRAL in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GRAL is in one of them and how their past GRAL trades turned out.
GRAIL is a healthcare company based in Sunnyvale, California, that develops blood tests for early cancer detection. Its main product, Galleri, screens for many types of cancer from a single blood draw and aims to indicate the organ or tissue where a cancer signal may come from. The company sells Galleri through partnerships with healthcare systems, employers, digital health platforms, payors and life insurance providers. Galleri is not yet approved by the U.S. Food and Drug Administration.